Updated September 11, 2026, 5:40 PM ET. This page is generated from CAMS research records and refreshes twice each trading day.
The Coverage Radar shows what the CAMS research desk is watching, what it has recently published, and every company with a published evidence review. It is impersonal market analysis for readers who follow the research; it contains no recommendations.
Recently published reviews
- CPRT: Copart after fiscal 2026 results | CAMS premium Premium (September 11, 2026)
- CHWY: CHWY, September 11, 2026 (September 11, 2026)
- CASY: Casey's General Stores: Q1 strength meets a sharp expectation reset (September 11, 2026)
- PHVS: PHVS Evidence Review: September 10, 2026 (September 10, 2026)
- DSGX: Descartes Systems Group Evidence Review: September 10, 2026 (September 10, 2026)
- SAIL: SailPoint Evidence Review: 2026-09-09 (September 9, 2026)
- ROIV: Roivant Sciences (September 8, 2026)
- KFY: Korn Ferry Evidence Review: 2026-09-04 (September 4, 2026)
- TTAN: TTAN evidence review (September 3, 2026)
- SUNB: SUNB evidence review (September 3, 2026)
- NAVN: NAVN evidence review (September 3, 2026)
- FDS: FactSet Evidence and Scenario Review: 2026-09-03 (September 3, 2026)
- CF: CF Nitrogen-Market Evidence and Scenario Review: 2026-09-03 (September 3, 2026)
- BRZE: BRZE evidence review (September 3, 2026)
- AEO: American Eagle Outfitters Evidence Review: 2026-09-03 (September 3, 2026)
- ABM: ABM evidence review (September 3, 2026)
- ZS: ZS evidence review (September 2, 2026)
- WLY: WLY evidence review (September 2, 2026)
- VSXY: VSXY evidence review (September 2, 2026)
- TTC: TTC evidence review (September 2, 2026)
- SNOW: SNOW evidence review (September 2, 2026)
- SLB: SLB evidence review (September 2, 2026)
- PATH: PATH evidence review (September 2, 2026)
- AVAH: AVAH evidence review (September 2, 2026)
On the radar
Companies the pre-market scan has queued for a full evidence review, with the catalyst that put them there. A listing here means research is pending, not that any view has been formed.
| Ticker | Catalyst | Catalyst date | Status |
|---|---|---|---|
| CVE | September 8 Middle East supply disruption pushed crude to a six-week high and reinforced the leading Energy tape. | September 8, 2026 | Queued |
| ASO | Fiscal Q2 2026 results before market and earnings call | September 9, 2026 | Queued |
| CHYM | Coverage cited target hikes tied to the Stride deal and raised guidance | September 9, 2026 | Queued |
| CMPS | 52-week Phase 3 COMP005 results for COMP360 reported | September 9, 2026 | Queued |
| HPE | Fresh quarterly-results digestion: scanner news cited $12.2B revenue and $1.0B free cash flow; issuer reconciliation... | September 9, 2026 | Queued |
| SIG | Fiscal quarterly results before market | September 9, 2026 | Queued |
| SSL | Secondary coverage linked the recent move to a debt-reduction narrative | September 9, 2026 | Queued |
| LFST | Coverage reported operating milestones that require primary-source confirmation | September 10, 2026 | Queued |
| M | Fiscal quarterly results before market | September 10, 2026 | Queued |
| NET | Coverage reported an upbeat outlook behind the price jump | September 10, 2026 | Queued |
| ORCL | Fiscal Q1 2027 results after market close | September 10, 2026 | Queued |
| SWKS | Merger-arbitrage repricing while China and South Korea reviews remain open | September 10, 2026 | Queued |
| VLO | Energy-sector jump linked to the oil shock; no company-specific event asserted | September 10, 2026 | Queued |
| KR | Fiscal quarterly results before market | September 11, 2026 | Queued |
| VIST | Energy led the sector tape; no company-specific catalyst was established | September 11, 2026 | Queued |
| ABVX | Nasdaq's official earnings calendar lists September 21 after-hours results. | September 21, 2026 | Queued |
| CTAS | Nasdaq's official earnings calendar lists September 23 earnings; time is not supplied. | September 23, 2026 | Queued |
| PAYX | Scanner-listed pre-market earnings date; issuer timing remains to be confirmed | September 23, 2026 | Queued |
| UEC | Scanner-listed tentative earnings date not corroborated by the issuer search | September 23, 2026 | Queued |
| KMX | Scheduled earnings; session timing unverified | September 24, 2026 | Queued |
| SNX | Scheduled pre-market earnings | September 24, 2026 | Queued |
| BLTE | FDA Priority Review of tinlarebant NDA for Stargardt disease | February 12, 2027 | Queued |
Today
- Morning Market Brief
- Sentinel activity logged for: WMT, NVDA, AVGO, MRVL, SPY/QQQ/SMH, U.S. MACRO / INFLATION / RATES / BROAD EQUITY RISK, HSY, U.S. MACRO / INFLATION / RATES / ENERGY / BROAD EQUITY RISK, COST, XLP / DEFENSIVE CONSUMER-STAPLES SECTOR, GLOBAL OIL / ENERGY SUPPLY / INFLATION RISK, CRWD, NVDA/AVGO/AMD/MRVL, CHD, AMD, NVDA/AMZN, MSFT, U.S. MACRO / RATES / BROAD EQUITY RISK, CL, U.S. CONSUMER SENTIMENT / CONSUMER-DEMAND AND INFLATION-EXPECTATIONS RISK
Coverage universe
47 companies with a published review, out of 142 tracked by the scan. Each link opens the most recent review.
How to read this page
Premium evidence reviews are available with a paid membership. The radar lists catalysts as reported by the companies or exchanges; a catalyst date can move. Nothing here is a signal to act, and the desk does not disclose positions.
Member log inJoin CAMS Premium
Market analysis, not personalized investment advice.